aid: catalym
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/catalym.png
name: CatalYm
description: CatalYm GmbH is a clinical-stage biotechnology company based in Planegg-Martinsried
  near Munich, Germany, developing next-generation cancer immunotherapies. Its lead approach
  neutralizes GDF-15 (Growth Differentiation Factor 15) to reverse a key immune-resistance
  mechanism in solid tumors, aiming to reinstate anti-tumor immune activity and overcome
  resistance to checkpoint-inhibitor and other cancer therapies. The company is a portfolio
  company of Canaan Partners. This is a biotech/pharmaceutical organization with no public
  developer API, SDK, or documentation surface; it is tracked in the API Evangelist network
  as a company profile rather than an API provider.
url: https://raw.githubusercontent.com/api-evangelist/catalym/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: biotechnology
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Immunotherapy
- Oncology
- Cancer
- Drug Development
- Germany
apis: []
common:
- type: Website
  url: https://www.catalym.com/
- type: PrivacyPolicy
  url: https://www.catalym.com/privacy-policy/
- type: Imprint
  url: https://www.catalym.com/imprint/
- type: LinkedIn
  url: https://www.linkedin.com/company/catalym/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence